Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
The Urologic Clinics of North America|February 1, 1996
Management of prostate and bladder cancer in the elderlyR Dreicer, C S Cooper, R D WilliamsInvestigational New Drugs|September 20, 2001
Phase II trial of GM-CSF in advanced prostate cancerR Dreicer, W A See, E A KleinUrology|September 1, 1994
Phase II trial of 5-fluorouracil and alpha-2b interferon in patients with hormone-refractory metastatic prostate cancerR Dreicer, P K Forest, R D WilliamsAmerican Journal of Clinical Oncology|August 1, 1997
Continuous infusion, intravesical doxorubicin for the treatment of regionally advanced bladder cancer: a phase I-II trialW A See, R Dreicer, P K Forest, et al.European Journal of Cancer & Clinical Oncology|February 1, 1984
High-dose cytosine arabinoside in multiple myelomaH Kantarjian, R Dreicer, B Barlogie, et al.Investigational New Drugs|January 19, 2000
Phase II trial of suramin in patients with metastatic renal cell carcinomaR Dreicer, D C Smith, R D Williams, et al.The Journal of Urology|November 1, 1990
Perioperative methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) for poor risk transitional cell carcinoma of the bladder: an Eastern Cooperative Oncology Group pilot studyR Dreicer, E M Messing, P J Loehrer, et al.Seminars in Cancer Biology|August 11, 2000
Second-generation interferons for cancer: clinical targetsE C Borden, D Lindner, R Dreicer, et al.The Journal of Urology|September 1, 1993
Neoadjuvant cisplatin, methotrexate and vinblastine for muscle-invasive bladder cancer: long-term followupR Dreicer, T A Kollmorgen, R F Smith, et al.Investigational New Drugs|January 1, 1996
Phase II trial of edatrexate in patients with metastatic colorectal cancerG H Clamon, C E Riggs, R Dreicer, et al.Pageof 6